INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium
Inovio, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that Thermo Fisher Scientific, the world leader in serving science, has signed a letter of intent to manufacture INOVIO’s DNA COVID-19 vaccine candidate INO-4800.
Thermo Fisher Scientific will join existing partners Richter-Helm BioLogics and UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), in INOVIO’s global manufacturing consortium.
Thermo Fisher Scientific Inc., acquired UF Innovate | Sid Martin Biotech alum Brammer Bio in 2019, founded by UF researcher Dr. Richard Snyder.
Learn more about INOVIO Adds Thermo Fisher Scientific To Global Manufacturing Consortium.Related news Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant.